The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, Peter C.·1976·Science
DOI 10.1126/science.959840

Cited by (1,016)

Items 501–600 of 1,016

  1. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases
    Lurdes Torres, Franclim R. Ribeiro, Nikos Pandis, Johan A. Andersen, Sverre Heim, Manuel Rodrigues Teixeira · 2006 · Breast Cancer Research and Treatment
  2. Spatial genomics maps the structure, nature and evolution of cancer clones
    Artem Lomakin, Jessica Svedlund, Carina Strell, Milana Gatarić, Artem Shmatko, Gleb D. Rukhovich, Jun Sung Park, Young Seok Ju, Stefan C. Dentro, Vitalii Kleshchevnikov et al. · 2022 · Nature
  3. The p53 gene and its role in human brain tumors
    Oliver Bögler, Hui Huang, Paul Kleihues, Webster K. Cavenee · 1995 · Glia
  4. Identification of Genetic Markers for Prostatic Cancer Progression
    Janneke C. Alers, Jenneke Rochat, Pieter-Jaap Krijtenburg, Wim C.J. Hop, Ries Kranse C, Carla Rosenberg, Hans J. Tanke, Fritz H. Schröder, Herman van Dekken · 2000 · Laboratory Investigation
  5. Multistep Carcinogenesis: A Chain Reaction of Aneuploidizations
    PETER H. DUESBERG, Ruhong Li · 2003 · Cell Cycle
  6. Tumor suppressor genetics
    Shannon R. Payne, Christopher J. Kemp · 2005 · Carcinogenesis
  7. Trisomy 7 in nonneoplastic cells
    Bertil Johansson, Sverre Heim, Nils Mandahl, Fredrik Mertens, Felix Mitelman · 1993 · Genes Chromosomes and Cancer
  8. Expanding the computational toolbox for mining cancer genomes
    Li Ding, Michael C. Wendl, Joshua F. McMichael, Benjamin J. Raphael · 2014 · Nature Reviews Genetics
  9. A practical guide to cancer subclonal reconstruction from DNA sequencing
    Maxime Tarabichi, Adriana Salcedo, Amit G. Deshwar, Máire Ní Leathlobhair, Jeff A. Wintersinger, David C. Wedge, Peter Van Loo, Quaid Morris, Paul Christopher Boutros · 2021 · Nature Methods
  10. Therapeutic Effects of Coumarins with Different Substitution Patterns
    Virginia Flores‐Morales, Ana P. Villasana-Ruíz, Idalia Garza Veloz, Samantha González Delgado, Margarita L. Martínez‐Fierro · 2023 · Molecules
  11. Evolution of the cancer genome
    Podlaha, Ondrej, Riester, Markus, De, Subhajyoti, Michor, Franziska · 2012 · Trends in Genetics
  12. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution
    Henry H. Heng, Steven W. Bremer, Joshua B. Stevens, Steven D. Horne, Guo Liu, Batoul Y. Abdallah, Karen J. Ye, Christine J. Ye · 2013 · Cancer and Metastasis Reviews
  13. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
    Wenxuan Du, Olivier Elemento · 2014 · Oncogene
  14. T he M olecular B iology of M ucosal F ield C ancerization of the H ead and N eck
    Patrick K. Ha, Joseph A. Califano · 2003 · Critical Reviews in Oral Biology & Medicine
  15. Tumor dedifferentiation: An important step in tumor invasion
    Helmut Erich Gabbert, Rudolf Wagner, Roland Moll, Claus‐Dieter Gerharz · 1985 · Clinical & Experimental Metastasis
  16. mTOR pathway in colorectal cancer: an update
    Maria Giovanna Francipane, Eric Lagasse · 2013 · Oncotarget
  17. Darwinian medicine: a case for cancer
    Melvyn F. Greaves · 2007 · Nature reviews. Cancer
  18. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Carolyn S. Grove, George S. Vassiliou · 2014 · Disease Models & Mechanisms
  19. Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
    Said M. Afify, Masaharu Seno · 2019 · Cancers
  20. Barrett's esophagus: Cell cycle abnormalities in advancing stages of neoplastic progression
    Brian J. Reid, Carissa A. Sanchez, Patricia L. Blount, Douglas S. Levine · 1993 · Gastroenterology
  21. How many kinds of individual are there?
    Bernabé Santelices · 1999 · Trends in Ecology & Evolution
  22. Principles and mechanisms of non-genetic resistance in cancer
    Charles C. Bell, Omer Gilan · 2019 · British Journal of Cancer
  23. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail.
    John G. Strickler, Jianping Zheng, Q Shu, L J Burgart, S R Alberts, Darryl K. Shibata · 1994 · PubMed
  24. The biology of cancer metastasis and implications for therapy
    Isaiah J. Fidler, Charles M. Blach · 1987 · Current Problems in Surgery
  25. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapy
    Pablo Uribe, Sergio González · 2011 · Pathology - Research and Practice
  26. Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution
    Bram Van den Bergh, Toon Swings, Maarten Fauvart, Jan Jacques Michiels · 2018 · Microbiology and Molecular Biology Reviews
  27. Generation of phenotypic diversity and progression in metastatic tumor cells
    Garth L. Nicolson · 1984 · Cancer and Metastasis Reviews
  28. The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis
    Ian R. Hart, Isaiah J. Fidler · 1981 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  29. Age-specific incidence of cancer: Phases, transitions, and biological implications
    Rafael Meza, Jihyoun Jeon, Suresh H. Moolgavkar, E. Georg Luebeck · 2008 · Proceedings of the National Academy of Sciences
  30. How Does Multistep Tumorigenesis Really Proceed?
    Christine Louise Chaffer, Robert A. Weinberg · 2015 · Cancer Discovery
  31. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
    Miryam Müller, Thomas Graham Bird, Jean‐Charles Nault · 2020 · Journal of Hepatology
  32. Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms
    Bernhard Tribukait · 1987 · World Journal of Urology
  33. Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
    Susanna L. Cooke, Charlotte K.Y. Ng, Nataliya Melnyk, María J. García, Thomas J. Hardcastle, Jillian Temple, Simon P. Langdon, David D. Huntsman, James D. Brenton · 2010 · Oncogene
  34. Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
    Robert S. Kerbel · 1990 · Advances in cancer research
  35. Normal diploid human and rodent cells lack a detectable frequency of gene amplification.
    Thea Dorothy Tlsty · 1990 · Proceedings of the National Academy of Sciences
  36. Microsatellite instability: The mutator that mutates the other mutator
    Manuel Perucho · 1996 · Nature Medicine
  37. What does physics have to do with cancer?
    Franziska Michor, Jan Liphardt, Mauro Ferrari B, Jonathan Widom · 2011 · Nature reviews. Cancer
  38. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: Implications for methylation-associated cellular processes
    Thomas Haaf · 1995 · Pharmacology & Therapeutics
  39. Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene
    M. Stephen Meyn · 1999 · Clinical Genetics
  40. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas
    Philip Quirke, Michael F. Dixon, Andrew D. Clayden, Paul Durdey, John E. D. Dyson, Norman S. Williams, Colin C. Bird · 1987 · The Journal of Pathology
  41. Proliferation and invasion: Plasticity in tumor cells
    Chong-Feng Gao, Qian Reuben Xie, Yanli Su, Julie M. Koeman, Sok Kean Khoo, Margaret F. Gustafson, Beatrice S. Knudsen, Rick V. Hay, Nariyoshi Shinomiya, George F. Vande Woude · 2005 · Proceedings of the National Academy of Sciences
  42. The Chromosomal Basis of Cancer
    PETER H. DUESBERG, Ruhong Li, Alice Charlotte Fabarius, Rüediger Hehlmann · 2005 · Analytical Cellular Pathology
  43. Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model
    Carey, Shawn P., Starchenko, Alina, McGregor, Alexandra L., Reinhart-King, Cynthia A. · 2013 · Clinical & Experimental Metastasis
  44. Identification and targeting of cancer stem cells
    Tobias Schatton, Natasha Y. Frank, Markus H. Frank · 2009 · BioEssays
  45. Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?
    Valentin S. Bruttel, Jöerg Wischhusen · 2014 · Frontiers in Immunology
  46. Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance
    Devon M. Fitzgerald, P. J. Hastings, Susan M. Rosenberg · 2016 · Annual Review of Cancer Biology
  47. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells
    Ruhong Li, George Yerganian, PETER H. DUESBERG, Alwin Kraemer, Andreas Willer, Charlotte Rausch, Rüediger Hehlmann · 1997 · Proceedings of the National Academy of Sciences
  48. Genomic Instability and Tumor Progression: Mechanistic Considerations
    Keith C. Cheng, Lawrence A. Loeb · 1992 · Advances in cancer research
  49. Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.
    Lars L. Vindeløv, Heine Høi Hansen, Ib Jarle Christensen, Mogens Spang‐Thomsen, Fred R. Hirsch, Mogens Hansen, Nis I. Nissen · 1980 · PubMed
  50. The Epigenetic Hallmarks of Cancer
    Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz Virgilia Rassool, Peter A. Jones, Stephen B. Baylin · 2024 · Cancer Discovery
  51. The biology of head and neck cancer stem cells
    Zhaocheng Zhang, Manoel Sant’Ana Filho, Jacques Eduardo Nor · 2011 · Oral Oncology
  52. Involvement of Lgl and Mahjong/VprBP in Cell Competition
    Yoichiro Tamori, Carl Uli Bialucha, Aiguo Tian, Mihoko Kajita, Yi‐Chun Huang, Mark Norman, Nicholas Harrison, John Poulton, Kenzo Ivanovitch, Lena Disch et al. · 2010 · PLoS Biology
  53. An immersed boundary framework for modelling the growth of individual cells: An application to the early tumour development
    Katarzyna Anna Rejniak · 2007 · Journal of Theoretical Biology
  54. Pathogenesis of adult testicular germ cell tumors
    Bauke M. de Jong, J. Wolter Oosterhuis, Sérgio M.M.J. Castedo, AnneMarie Vos, Gerard J. te Meerman · 1990 · Cancer Genetics and Cytogenetics
  55. Molecular characterization and targeted therapeutic approaches in breast cancer
    Angela Toss, Massimo Cristofanilli · 2015 · Breast Cancer Research
  56. Reconstructing metastatic seeding patterns of human cancers
    Johannes G. Reiter, Alvin P. Makohon-Moore, Jeffrey M. Gerold, Ivana Božić, Krishnendu Chatterjee, Christine A. Iacobuzio–Donahue, Bert Vogelstein, Martin A. Nowak · 2017 · Nature Communications
  57. Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines
    Fred Gilbert, Gloria B. Balaban, Paul S. Moorhead, Diana W. Bianchi, Harvey R. Schlesinger · 1982 · Cancer Genetics and Cytogenetics
  58. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes
    Bernhard Holzmann, Eva‐Bettina Bröcker, Jürgen M. Lehmann, Dirk J. Ruiter, Clemens Sorg, Gert Riethmüller, Judith P. Johnson · 1987 · International Journal of Cancer
  59. The origins of cancer robustness and evolvability
    Tianhai Tian, Sarah Olson, James M. Whitacre, Angus Silas Harding · 2010 · Integrative Biology
  60. Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
    Salvador J. Díaz‐Cano · 2012 · International Journal of Molecular Sciences
  61. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
    Rosalba Camicia, Hans Christian Winkler, Paul O. Hassa · 2015 · Molecular Cancer
  62. DNA Amplification by Breakage/Fusion/Bridge Cycles Initiated by Spontaneous Telomere Loss in a Human Cancer Cell Line
    Anthony W.I. Lo, Laure Sabatier, Bijan Fouladi, Géraldine Pottier, Michelle Ricoul, John P. Mumane · 2002 · Neoplasia
  63. TP53 andMYC gene alterations independently predict poor prognosis in breast cancer patients
    Els M.J.J. Berns, Jan G.M. Klijn, Marcel Smid, Iris L. van Staveren, Maxime P. Look, Wim L.J. van Putten, John A. Foekens · 1996 · Genes Chromosomes and Cancer
  64. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis
    Ranjit S. Bindra, Peter M. Glazer · 2004 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  65. Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
    Stefano Fais, Giulietta Venturi, Bob Gatenby · 2014 · Cancer and Metastasis Reviews
  66. Ecological Therapy for Cancer: Defining Tumors Using an Ecosystem Paradigm Suggests New Opportunities for Novel Cancer Treatments
    Kenneth J. Pienta, Natalie McGregor, Robert Axelrod, David E. Axelrod · 2008 · Translational Oncology
  67. Chromosome segregation and genomic stability
    Viji M. Draviam, Stephanie Zhi-Juan Xie, Peter Karl Sorger · 2004 · Current Opinion in Genetics & Development
  68. Spontaneous regression of cancer
    Rose J. Papac · 1996 · Cancer Treatment Reviews
  69. Heterogeneity of cancer cells from a single human colon carcinoma
    Daniel L. Dexter, Ellen N. Spremulli, Zuzana Fligiel, James A. Barbosa, Renee Vogel, Abby VanVoorhees, Paul Calabresi · 1981 · The American Journal of Medicine
  70. Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
    Andrea Gras Navarro, Andreas T. Björklund, Martha Chekenya · 2015 · Frontiers in Immunology
  71. IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
    Bin Zhang, Theodore G Karrison, Donald A. Rowley, Hans Wilhelm Schreiber · 2008 · Journal of Clinical Investigation
  72. Diagnosis and grading of dysplasia in Barrett’s oesophagus
    Robert Daniel Odze · 2006 · Journal of Clinical Pathology
  73. Cancer metastasis: A product of tumor-host interactions
    Everett V. Sugarbaker · 1979 · Current Problems in Cancer
  74. Chapter 10 The Cancer Cell–Leukocyte Fusion Theory of Metastasis
    John M. Pawelek, Ashok K. Chakraborty · 2008 · Advances in cancer research
  75. Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility
    Guohze Yang, Stefan J. Scherer, Scarlet S. Shell, Kan Yang, Mimi Kim, Martin Lipkin, Raju Kucherlapati, Richard David Kolodner, Winfried Edelmann · 2004 · Cancer Cell
  76. NG2 proteoglycan-binding peptides target tumor neovasculature.
    Michael A. Burg, Renata Pasqualini, Wadih Arap, Erkki I. Ruoslahti, William B. Stallcup · 1999 · PubMed
  77. Clonal evolution in hematological malignancies and therapeutic implications
    Dan Avi Landau, Scott L. Carter, Gad A. Getz, Catherine J. Wu · 2013 · Leukemia
  78. Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research.
    David Samuel Alberts, O. Michael Colvin, Allan H. Conney, Virginia L. Ernster, Jeff Garber, Peter Greenwald, Lorraine J. Gudas, Ki Hong Waun Ki Hong, Gary J. Kelloff, Robert A. Kramer et al. · 1999 · PubMed
  79. How aneuploidy affects metabolic control and causes cancer
    David Rasnick, PETER H. DUESBERG · 1999 · Biochemical Journal
  80. Normal stem cells and cancer stem cells: similar and different
    Mark J. Shackleton · 2010 · Seminars in Cancer Biology
  81. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice
    Caldwell, Christine M., Green, Rebecca A., Kaplan, Kenneth B. · 2007 · The Journal of Cell Biology
  82. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis
    Celià-Terrassa, Toni, Jolly, Mohit Kumar · 2020 · Cold Spring Harbor Perspectives in Medicine
  83. DNA replication fidelity and cancer
    Preston, Bradley D., Albertson, Tina M., Herr, Alan J. · 2010 · Seminars in Cancer Biology
  84. The Cancer Stem Cell Hypothesis: Failures and Pitfalls
    Maryam Rahman, Loic P. Deleyrolle, Vinata Vedam‐Mai, Hassan Azari, Muhammad M. Abd‐El‐Barr, Brent A. Reynolds · 2010 · Neurosurgery
  85. Evolutionary medicine: its scope, interest and potential
    Stephen C. Stearns · 2012 · Proceedings of the Royal Society B Biological Sciences
  86. Genetic insights into the morass of metastatic heterogeneity
    Kent W. Hunter, Ruhul Amin, Sarah K. Deasy, Ngoc‐Han Ha, Lalage M. Wakefield · 2018 · Nature reviews. Cancer
  87. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
    Nuzhat Ahmed, Ruth M. Escalona, Dilys T.H. Leung, Emily Chan, George Kannourakis · 2018 · Seminars in Cancer Biology
  88. A narrative review of tumor heterogeneity and challenges to tumor drug therapy
    Liang Wei Zhu, Minlin Jiang, Hao Wang, Hui Sun, Jun Zhu, Wencheng Zhao, Qiyu Fang, Jia Yu, Peixin Chen, Shengyu Wu et al. · 2021 · Annals of Translational Medicine
  89. Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma
    Larry E. Puls, Deborah E. Powell, Paul D. DePriest, Holly H. Gallion, James E. Hunter, Richard J. Kryscio, John Rensselaer van Nagell · 1992 · Gynecologic Oncology
  90. Stochastic cancer progression driven by non‐clonal chromosome aberrations
    Henry H. Heng, Joshua B. Stevens, Gou Liu, Steven W. Bremer, Karen J. Ye, Prem-veer Reddy, Gen Sheng Wu, Yanru Wang, Michael A. Tainsky, Christine J. Ye · 2006 · Journal of Cellular Physiology
  91. Evidence for Common Clonal Origin of Multifocal Lung Cancers
    Xiaoyan Wang, Mingsheng Wang, Gregory T. MacLennan, Fadi W. Abdul‐Karim, John N. Eble, Timothy D. Jones, Felix A. Olobatuyi, Rosana Eisenberg, Oscar W. Cummings, Shaobo Zhang et al. · 2009 · JNCI Journal of the National Cancer Institute
  92. The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy
    Robert D. Loberg, Deborah Bradley, Scott A. Tomlins, Arul M. Chinnaiyan, Kenneth J. Pienta · 2007 · CA A Cancer Journal for Clinicians
  93. Extraskeletal Myxoid Chondrosarcoma: A Clinicopathologic, Immunohistochemical, and Ploidy Analysis of 23 Cases
    André M. Oliveira, Thomas J. Sebo, James E. McGrory, Thomas A. Gaffey, Michael G. Rock, Antonio G. Nascimento · 2000 · Modern Pathology
  94. Genome Stability Requires p53
    Eischen, Christine M. · 2016 · Cold Spring Harbor Perspectives in Medicine
  95. Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain
    Simona Soverini, Caterina D. Benedittis, Kateřina Machová Poláková, Adéla Broučková, David Stephen Horner, Michele Iacono, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis et al. · 2013 · Blood
  96. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
    Tae‐Min Kim, Seung‐Hyun Jung, Chang Hyeok An, Sung Hak Lee, In-Pyo Baek, Min Sung Kim, Sung‐Won Park, Je‐Keun Rhee, Sug-Hyung Lee, Yeun‐Jun Chung · 2015 · Clinical Cancer Research
  97. Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy
    Ankur Sharma, Elaine Yiqun Cao, Vibhor Kumar, Xiaoqian Zhang, Hui Sun Leong, Angeline M.L. Wong, Neeraja Ramakrishnan, Muhammad Hakimullah, Hui Min Vivian Teo, Fui Teen Chong et al. · 2018 · Nature Communications
  98. Cancer stem cell mimicry for immune evasion and therapeutic resistance
    Phei Er Saw, Qiang Liu, Ping‐Pui Wong, Erwei Song · 2024 · Cell stem cell
  99. The Cellular Basis of Tumor Progression
    Gloria H. Heppner, Fred R. Miller · 1997 · International review of cytology
  100. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Chen‐Yang Shen, J.-C. Yu, Y.-L. Lo, C H Kuo, C T Yue, Yuh‐Shan Jou, Chiun‐Sheng Huang, J C Lung, Cheng-Han Wu · 2000 · PubMed